Eshaghi, A.
946  Ergebnisse:
Personensuche X
?
1

Targeted amplification-based whole genome sequencing of Mon..:

S. Isabel ; A. Eshaghi ; V. R. Duvvuri...
https://journals.asm.org/doi/10.1128/spectrum.02979-23.  , 2024
 
?
2

Targeted amplification-based whole genome sequencing of Mon..:

Isabel, S ; Eshaghi, A ; Duvvuri, V. R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10783113/.  , 2023
 
?
3

Real-world effectiveness of ocrelizumab in a UK multi-centr..:

Abdel-Mannan, O ; Eshaghi, A ; Champsas, D...
https://discovery.ucl.ac.uk/id/eprint/10161703/1/Ocrelizumab%20ECTRIMS%202022%20poster%2014102022.pdf.  , 2022
 
?
4

B Cells in the CNS at Postmortem Are Associated With Worse ..:

Moccia, M ; Haider, L ; Eshaghi, A...
https://discovery.ucl.ac.uk/id/eprint/10138451/1/Barkhof_B%20Cells%20in%20the%20CNS%20at%20Postmortem%20Are%20Associated%20With%20Worse%20Outcome%20and%20Cell%20Types%20in%20Multiple%20Sclerosis_VoR.pdf.  , 2022
 
?
5

Spatial patterns of brain lesions assessed through covarian..:

Tur C ; Grussu F ; De Angelis F...
info:eu-repo/semantics/altIdentifier/pmid/34875458.  , 2022
 
?
6

Assessing Neurofilaments as Biomarkers of Neuroprotection i..:

Williams, TE ; Holdsworth, KP ; Nicholas, JM...
https://discovery.ucl.ac.uk/id/eprint/10142448/1/Chataway_Assessing%20Neurofilaments%20as%20Biomarkers%20of%20Neuroprotection%20in%20Progressive%20Multiple%20Sclerosis_VoR.pdf.  , 2022
 
?
 
?
8

MOF-mediated synthesis of CuO/CeO2 composite nanoparticles:..:

Farhangi M. J ; Es-Haghi A ; Yazdi M. E. T..
info:eu-repo/semantics/altIdentifier/wos/WOS:000744026600001.  , 2021
 
?
9

Predicting disability progression and cognitive worsening i..:

Colato, E ; Stutters, J ; Tur, C...
https://discovery.ucl.ac.uk/id/eprint/10126762/1/jnnp-2020-325610.full.pdf.  , 2021
 
?
10

pySuStaIn: A Python implementation of the Subtype and Stage..:

Aksman, LM ; Wijeratne, PA ; Oxtoby, NP...
https://discovery.ucl.ac.uk/id/eprint/10135908/1/1-s2.0-S2352711021001096-main.pdf.  , 2021
 
?
11

Identifying multiple sclerosis subtypes using unsupervised ..:

Eshaghi, A ; Young, A ; Wijeratne, PA...
https://discovery.ucl.ac.uk/id/eprint/10123637/1/s41467-021-22265-2.pdf.  , 2021
 
?
12

Staging and stratifying cognitive dysfunction in multiple s..:

Wojcik, C ; Fuchs, TA ; Tran, H...
https://discovery.ucl.ac.uk/id/eprint/10128498/3/Eshaghi_20201122_ebm_AE.docx%5B96%5D.pdf.  , 2021
 
?
13

Multiple Sclerosis in Children and Adults: Does Age Matter?:

Hacohen, Y ; Eshaghi, A
https://discovery.ucl.ac.uk/id/eprint/10136720/1/WNL.0000000000012866.full.pdf.  , 2021
 
?
14

Linking immune-mediated damage to neurodegeneration in mult..:

Groppa, S ; Gonzalez-Escamilla, G ; Eshaghi, A..
https://discovery.ucl.ac.uk/id/eprint/10138653/1/fcab237.pdf.  , 2021
 
?
15

Ordinal SuStaIn: Subtype and Stage Inference for Clinical S..:

Young, AL ; Vogel, JW ; Aksman, LM...
https://discovery.ucl.ac.uk/id/eprint/10135879/1/Alexander_Ordinal%20SuStaIn-%20Subtype%20and%20Stage%20Inference%20for%20Clinical%20Scores,%20Visual%20Ratings,%20and%20Other%20Ordinal%20Data_VoR.pdf.  , 2021
 
1-15